全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

OPG/RANKL/RANK信号通路在早发冠心病中的研究进展
Research Progress of OPG/RANKL/RANK Signaling Pathway in Premature Coronary Heart Disease

DOI: 10.12677/MD.2022.123037, PP. 231-236

Keywords: 骨保护素,核因子kB受体激活剂,核因子受体激活蛋白配体,早发冠心病
Osteoprotegerin
, Nuclear Factor kB Receptor Activator, Nuclear Factor Receptor Activating Protein Ligand, Premature Coronary Heart Disease

Full-Text   Cite this paper   Add to My Lib

Abstract:

早发冠状动脉粥样硬化性心脏病(premature coronary heart disease, PCHD)是冠状动脉粥样硬化性心脏病(coronary atherosclerotic heart disease, CHD)特有的种类,具有起病急、发病隐匿、年轻化、高病发率、高致死率等特征,会带来严重的不良后果。过去关于OPG/RANKL/RANK信号轴在骨骼系统发面研究的较多,近年来在心血管疾病(cardiovascular disease, CVD)的研究中也引起了广泛关注,因此探索对PCHD有意义的信号轴对于今后PCHD的发生、演变、治疗、预后等十分有意义。
Premature coronary heart disease (PCHD) is a unique type of coronary atherosclerotic heart disease (CHD). With acute onset, hidden onset, young, high incidence, high mortality and other characteristics, it will bring serious adverse consequences. In the past, there have been many studies on OPG/RANKL/RANK signal axis in skeletal system. In recent years, it has also attracted wide attention in the studies of cardiovascular disease (CVD). Therefore, the exploration of significant signal axis for PCHD is of great significance for the occurrence, evolution, treatment and prognosis of PCHD in the future.

References

[1]  中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6): 521-545.
[2]  Wang, H., Liu, Z., Shao, J., et al. (2020) Pathogenesis of Premature Coronary Artery Disease: Focus on Risk Factors and Genetic Variants. Genes and Diseases, 9, 370-380.
https://doi.org/10.1016/j.gendis.2020.11.003
[3]  Kovács, B., Vajda, E. and Nagy, E.E. (2019) Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Inter-face in Osteoarthritis. International Journal of Molecular Sciences, 20, Article No. 4653.
https://doi.org/10.3390/ijms20184653
[4]  Delpino, M.V. and Quarleri, J. (2020) Influence of HIV INFECTION and Antiretroviral Therapy on Bone Homeostasis. Frontiers in Endocrinology (Lausanne), 11, Article No. 502.
https://doi.org/10.3389/fendo.2020.00502
[5]  Hofbauer, L.C. and Heufelder, A.E. (1997) Osteoprotegerin: A Novel Local Player in Bone Metabolism. European Journal of Endocrinology, 137, 345-346.
https://doi.org/10.1530/eje.0.1370345
[6]  Infante, M., Fabi, A., Cognetti, F., et al. (2019) RANKL/RANK/OPG System beyond Bone Remodeling: Involvement in Breast Cancer and Clinical Perspectives. Journal of Experimental & Clinical Cancer Research, 38, Article No. 12.
https://doi.org/10.1186/s13046-018-1001-2
[7]  Venuraju, S.M., Yerramasu, A., Corder, R., et al. (2010) Osteo-protegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity. Journal of the Ameri-can College of Cardiology, 55, 2049-2061.
https://doi.org/10.1016/j.jacc.2010.03.013
[8]  Simonet, W.S., Lacey, D.L., Dunstan, C.R., et al. (1997) Osteopro-tegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density. Cell, 89, 309-319.
https://doi.org/10.1016/S0092-8674(00)80209-3
[9]  Carrillo-López, N., Martínez-Arias, L., Fernández-Villabrille, S., et al. (2021) Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disor-ders. Calcified Tissue International, 108, 439-451.
https://doi.org/10.1007/s00223-020-00803-2
[10]  Tobeiha, M., Moghadasian, M.H., Amin, N., et al. (2020) RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling. BioMed Research In-ternational, 2020, Article ID: 6910312.
https://doi.org/10.1155/2020/6910312
[11]  Pieralice, S., Vigevano, F., Del Toro, R., Napoli, N. and Maddaloni, E. (2018) Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis. Current Diabetes Reports, 18, Arti-cle No. 84.
https://doi.org/10.1007/s11892-018-1060-y
[12]  Naranjo, M.C., Bermudez, B., Garcia, I., et al. (2017) Dietary Fatty Acids on Aortic Root Calcification in Mice with Metabolic Syndrome. Food and Function, 8, 1468-1474.
https://doi.org/10.1039/C7FO00143F
[13]  Tamtaji, O.R., Borzabadi, S., Ghayour-Mobarhan, M., Ferns, G. and Asemi, Z. (2019) The Effects of Fatty Acids Consumption on OPG/RANKL/RANK System in Cardiovascular Diseases: Current Status and Future Perspectives for the Impact of Diet-Gene Interaction. Journal of Cellular Biochemistry, 120, 2774-2781.
https://doi.org/10.1002/jcb.27672
[14]  Gu, W., Wang, Z., Sun, Z., et al. (2020) Role of NFATc1 in the Bone-Vascular Axis Calcification Paradox. Journal of Cardiovascular Pharmacology, 75, 200-207.
https://doi.org/10.1097/FJC.0000000000000788
[15]  Sandberg, W.J. (2006) Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome: Possible Role in Plaque Destabilization. Arteriosclerosis Thrombosis & Vascular Biology, 26, 857-863.
https://doi.org/10.1161/01.ATV.0000204334.48195.6a
[16]  刘倩茹. 血浆骨保护素水平与早发冠心病的相关性研究[D]: [硕士学位论文]. 延安: 延安大学, 2020.
[17]  边娟. 血浆骨保护素对早发急性冠脉综合征危险分层预测价值研究[D]: [硕士学位论文]. 延安: 延安大学, 2021.
[18]  Efstratiadis, G., Koskinas, K. and Pagourelias, E. (2007) Coronary Calcification in Patients with End-Stage Renal Disease: A Novel Endocrine Disorder? Hormones (Ath-ens), 6, 120-131.
https://doi.org/10.14310/horm.2002.111108
[19]  García-Gómez, M.C. and Vilahur, G. (2020) Osteoporosis and Vascular Calcification: A Shared Scenario. Osteoporosis y calcificación vascular: Un escenario com-partido. Clínica e Investigación en Arteriosclerosis, 32, 33-42.
https://doi.org/10.1016/j.arteri.2019.03.008
[20]  Greenland, P. and Lloyd-Jones, D.M. (2022) Role of Coronary Artery Calcium Testing for Risk Assessment in Primary Prevention of Atherosclerotic Cardiovascular Disease: A Re-view. JAMA Cardiology, 7, 219-224.
https://doi.org/10.1001/jamacardio.2021.3948
[21]  WHO (2016) The Challenge of Cardiovascular Disease—Quick Statistics. http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cardiovascular-diseases/data-and-statistics
[22]  Joseph, P., Leong, D., McKee, M., et al. (2017) Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epi-demiology and Risk Factors. Circulation Research, 121, 677-694.
https://doi.org/10.1161/CIRCRESAHA.117.308903
[23]  Smith, C.L., Seigerman, M., Adusumalli, S., et al. (2021) Evolution and Outcomes of Premature Coronary Artery Disease. Current Cardiology Reports, 23, Article No. 36.
https://doi.org/10.1007/s11886-021-01457-8
[24]  An, T., Hao, J., Sun, S., et al. (2017) Efficacy of Statins for Os-teoporosis: A Systematic Review and Meta-Analysis. Osteoporosis International, 28, 47-57.
[25]  de Carvalho, R.D.P., Casarin, R.C.V., de Lima, P.O., et al. (2021) Statins with Potential to Control Periodontitis: From Biological Mechanisms to Clinical Studies. Journal of Oral Biosciences, 63, 232-244.
https://doi.org/10.1016/j.job.2021.06.002
[26]  Satny, M., Hubacek, J.A. and Vrablik, M. (2021) Statins and In-flammation. Current Atherosclerosis Reports, 23, Article No. 80.
https://doi.org/10.1007/s11883-021-00977-6
[27]  Giaginis, C., Papadopouli, A., Zira, A., et al. (2012) Correlation of Plasma Osteoprotegerin (OPG) and Receptor Activator of the Nuclear Factor κB Ligand (RANKL) Levels with Clini-cal Risk Factors in Patients with Advanced Carotid Atherosclerosis. Medical Science Monitor, 18, CR597-CR604.
https://doi.org/10.12659/MSM.883485

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133